Edgewise Therapeutics, Inc. (EWTX)
30.37
-0.29
(-0.95%)
USD |
NASDAQ |
Feb 12, 16:00
30.52
+0.15
(+0.49%)
Pre-Market: 09:02
Edgewise Therapeutics Cash from Investing (Quarterly) : 35.72M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Dynavax Technologies Corp. | 27.32M |
| Omeros Corp. | -6.861M |
| Gilead Sciences, Inc. | -1.835B |
| Agios Pharmaceuticals, Inc. | 95.56M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -34.78M |
| Cash from Financing (Quarterly) | 1.659M |
| Free Cash Flow | -132.64M |
| Free Cash Flow Per Share (Quarterly) | -0.3305 |
| Free Cash Flow to Equity (Quarterly) | -34.68M |
| Free Cash Flow to Firm (Quarterly) | -34.86M |
| Free Cash Flow Yield | -4.36% |